{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T03:36:46Z","timestamp":1785641806716,"version":"3.56.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Bacterial infections pose a major global public health threat. While antibiotics have historically served as the primary treatment, the rapid rise of antibiotic resistance has led to an urgent need for new therapeutic strategies. Host-directed therapies (HDTs), which activate defense mechanisms of host cells, are emerging as a promising alternative. Host-acting compounds (HACs) have no direct effect on bacteria and therefore do not induce drug resistance or alter intestinal microbiota composition. In the present study, we demonstrated that phenothiazines significantly enhance the antibacterial capacity of macrophages. In macrophages treated with phenothiazines, we observed a significant increase in lysosomal activity, induction of autophagy, and accumulation of reactive oxygen species (ROS). Importantly, co-treatment with autophagy inhibitors or ROS scavengers markedly diminished the antibacterial effects of phenothiazines. Furthermore, perphenazine (PHZ) effectively reduced organ lesions and inflammation associated with\n                    <jats:italic>S.<\/jats:italic>\n                    Typhimurium infections\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Our results demonstrated that phenothiazines are lead compounds for antibacterial agents via HDTs.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1712724","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:27:59Z","timestamp":1764311279000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Phenothiazines enhance antibacterial activity of macrophage by inducing ROS and autophagy"],"prefix":"10.3389","volume":"16","author":[{"given":"Lihao","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1176667","article-title":"Antibiotics for emerging pathogens","volume":"325","author":"Fischbach","year":"2009","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3975","article-title":"Platforms for antibiotic discovery","volume":"12","author":"Lewis","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2010.00134","article-title":"A brief history of the antibiotic era: lessons learned and challenges for the future","volume":"1","author":"Aminov","year":"2010","journal-title":"Front Microbiol"},{"key":"B4","volume-title":"Novel Antimicrobial Drug Development and Access: US Government Support and Opportunities","author":"Sullivan","year":"2024"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fux016","article-title":"Bacterial pathogens, antibiotics and antibiotic resistance","volume":"41","author":"Banin","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13664","article-title":"Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections","volume":"174","author":"Kamaruzzaman","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/biomedicines11020413","article-title":"Nanotechnology as a promising approach to combat multidrug resistant bacteria: a comprehensive review and future perspectives","volume":"11","author":"Hetta","year":"2023","journal-title":"Biomedicines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1356540","DOI":"10.1155\/2019\/1356540","article-title":"Intracellular pathogens: host immunity and microbial persistence strategies","volume":"2019","author":"Thakur","year":"2019","journal-title":"J Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1011088","DOI":"10.1371\/journal.ppat.1011088","article-title":"Deficiency in Galectin-3,-8, and-9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens","volume":"19","author":"Morrison","year":"2023","journal-title":"PloS Pathog"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113816","article-title":"Serine\/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription","volume":"43","author":"Scott","year":"2024","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2128","article-title":"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies","volume":"7","author":"Flannagan","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.599931","article-title":"Copy number heterogeneity in the virulence plasmid of Salmonella enterica","volume":"11","author":"S\u00e1nchez-Romero","year":"2020","journal-title":"Front Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.050","article-title":"Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses","volume":"150","author":"Dong","year":"2012","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02567\u201314","article-title":"Escape of actively secreting Shigella flexneri from ATG8\/LC3-positive vacuoles formed during cell-to-cell spread is facilitated by IcsB and VirA","volume":"6","author":"Campbell-Valois","year":"2015","journal-title":"MBio"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1004522","DOI":"10.1371\/journal.ppat.1004522","article-title":"Structure and specificity of the bacterial cysteine methyltransferase effector NleE suggests a novel substrate in human DNA repair pathway","volume":"10","author":"Yao","year":"2014","journal-title":"PloS Pathog"},{"key":"B19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.chom.2017.07.020","article-title":"Legionella pneumophila modulates mitochondrial dynamics to trigger metabolic repurposing of infected macrophages","volume":"22","author":"Escoll","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s41467-021-21186-4","article-title":"Salmonella Typhimurium reprograms macrophage metabolism via T3SS effector SopE2 to promote intracellular replication and virulence","volume":"12","author":"Jiang","year":"2021","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2022.01.006","article-title":"Host-acting antibacterial compounds combat cytosolic bacteria","volume":"30","author":"Liu","year":"2022","journal-title":"Trends Microbiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.05.010","article-title":"Postantibiotic leukocyte enhancement-mediated reduction of intracellular bacteria by macrophages","volume":"58","author":"Wu","year":"2024","journal-title":"J Adv Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0924-8579(02)00110-3","article-title":"Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus","volume":"20","author":"Ordway","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00326-16","article-title":"New role for FDA-approved drugs in combating antibiotic-resistant bacteria","volume":"60","author":"Andersson","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02985-15","article-title":"Thioridazine as chemotherapy for Mycobacterium avium complex diseases","volume":"60","author":"Deshpande","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2024.01.011","article-title":"Repurposing loperamide as an anti-infection drug for the treatment of intracellular bacterial pathogens","volume":"39","author":"Liu","year":"2024","journal-title":"Engineering"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e55692","DOI":"10.7554\/eLife.55692","article-title":"The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection","volume":"9","author":"Giraud-Gatineau","year":"2020","journal-title":"Elife"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-111315-125125","article-title":"The lysosome as a regulatory hub","volume":"32","author":"Perera","year":"2016","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0185-4","article-title":"Lysosomes as dynamic regulators of cell and organismal homeostasis","volume":"21","author":"Ballabio","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15602","article-title":"The lysosomal membrane\u2014export of metabolites and beyond","volume":"288","author":"Rudnik","year":"2021","journal-title":"FEBS J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.14.618295","article-title":"Cell-Type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorder","author":"Ghoochani","year":"2024","journal-title":"bioRxiv"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: molecular mechanisms and biological functions of autophagy","volume":"6","author":"Levine","year":"2004","journal-title":"Dev Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8933","DOI":"10.3390\/ijms21238933","article-title":"The protective effects of the autophagic and lysosomal machinery in vascular and valvular calcification: a systematic review","volume":"21","author":"Neutel","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20170055","article-title":"Dysregulation of autophagy as a common mechanism in lysosomal storage diseases","volume":"61","author":"Seranova","year":"2017","journal-title":"Essays Biochem"},{"key":"B36","first-page":"77","volume-title":"LC3 and autophagy","author":"Tanida","year":"2008"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Levine","year":"2010","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2167689","article-title":"Inhibition of autophagy in microglia and macrophages exacerbates innate immune responses and worsens brain injury outcomes","volume":"19","author":"Hegdekar","year":"2023","journal-title":"Autophagy"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cells1030372","article-title":"Regulation of autophagy by glucose in mammalian cells","volume":"1","author":"Moruno","year":"2012","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01243","article-title":"Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria","volume":"60","author":"Dharmaraja","year":"2017","journal-title":"J Med Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e202303066","DOI":"10.1083\/jcb.202303066","article-title":"Peroxisomal ROS control cytosolic Mycobacterium tuberculosis replication in human macrophages","volume":"222","author":"Pellegrino","year":"2023","journal-title":"J Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e101812","DOI":"10.15252\/embj.2019101812","article-title":"Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4","volume":"38","author":"Scherz\u2010Shouval","year":"2019","journal-title":"EMBO J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","author":"Ikuta","year":"2022","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.09.024","article-title":"Antibiotic resistance in dermatology: The scope of the problem and strategies to address it","volume":"86","author":"Shah","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"113966","DOI":"10.1016\/j.intimp.2024.113966","article-title":"Sesamol hinders the proliferation of intracellular bacteria by promoting fatty acid metabolism and decreasing excessive inflammation","volume":"146","author":"Jiang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00071","article-title":"The challenge of overcoming antibiotic resistance: an adjuvant approach","volume":"3","author":"Melander","year":"2017","journal-title":"ACS Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat Chem Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.719-726.2003","article-title":"Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus","volume":"47","author":"Kaatz","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00661-08","article-title":"RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine","volume":"52","author":"Bailey","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.03.014","article-title":"Ethidium bromide efflux by Salmonella: modulation by metabolic energy, pH, ions and phenothiazines","volume":"38","author":"Amaral","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuz017","article-title":"Do phenothiazines possess antimicrobial and efflux inhibitory properties","volume":"43","author":"Grimsey","year":"2019","journal-title":"FEMS Microbiol Rev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2009.09.027","article-title":"Thioridazine protects the mouse from a virulent infection by Salmonella enterica serovar Typhimurium 74","volume":"35","author":"Dasgupta","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.08.035","article-title":"Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection","volume":"145","author":"Conway","year":"2013","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.1984656","article-title":"Full-coverage regulations of autophagy by ROS: from induction to maturation","volume":"18","author":"Zhou","year":"2022","journal-title":"Autophagy"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1712724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:28:00Z","timestamp":1764311280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1712724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2025.1712724"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1712724","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"article-number":"1712724"}}